NCT02193464 Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk
| NCT ID | NCT02193464 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kyungpook National University Hospital |
| Condition | Idiopathic Chronic Inflammatory Bowel Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2014-09 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2014-09 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to investigate the incidence and natural course of inflammatory bowel disease in the southeastern area of Korea.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of inflammatory bowel disease including Crohn's disease and ulcerative colitis * Followed up for at least 6 months for the correct diagnosis Exclusion Criteria: * Patients who do not live in Daegu-Gyeongbuk province
Contact & Investigator
Eun Soo Kim, MD, PhD
PRINCIPAL INVESTIGATOR
Keimyung University School of Medicine
Frequently Asked Questions
Who can join the NCT02193464 clinical trial?
This trial is open to participants of all sexes, studying Idiopathic Chronic Inflammatory Bowel Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02193464 currently recruiting?
Yes, NCT02193464 is actively recruiting participants. Contact the research team at dandy813@hanmail.net for enrollment information.
Where is the NCT02193464 trial being conducted?
This trial is being conducted at Daegu, South Korea.
Who is sponsoring the NCT02193464 clinical trial?
NCT02193464 is sponsored by Kyungpook National University Hospital. The principal investigator is Eun Soo Kim, MD, PhD at Keimyung University School of Medicine. The trial plans to enroll 100 participants.